epirubicin has been researched along with Cardiomegaly in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, C; Chang, Y; Choi, S; Liu, X; Pan, Z; Zhang, X | 1 |
| Arnold, I; Shipman, KE | 1 |
2 other study(ies) available for epirubicin and Cardiomegaly
| Article | Year |
|---|---|
Blocking Store-Operated Ca
Topics: Animals; Calcium Channels; Cardiomegaly; Cardiotoxicity; Epirubicin; Humans; Mice; Myocytes, Cardiac | 2023 |
Case of epirubicin-induced cardiomyopathy in familial cardiomyopathy.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cardiac Myosins; Cardiomegaly; Cardiomyopathy, Dilated; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Death, Sudden, Cardiac; Dothiepin; Dyspnea; Epirubicin; Female; Fluorouracil; Heart Failure; Humans; Male; Mastectomy, Segmental; Middle Aged; Migraine Disorders; Mutation, Missense; Myosin Heavy Chains; Point Mutation; Radiotherapy, Adjuvant | 2011 |